Immunomeeting Seminar Series
The Immunomeeting Seminar Series is held at the University of Basel's Department of Biomedicine (Hebelstrasse) on Mondays during term time. Researchers from the various uBICo member groups present their work at these weekly meetings, in addition to invited guest speakers and uBICo distinguished speakers.
The uBICo Distinguished Immunology Speakers series sees leading researchers from around the world present their work at the Immunomeetings, which are then held in the ZLF Small Lecture Theater. These speakers partake in an extended programme during their visit to Basel which sees them spending the day with faculty and students at the Department of Biomedicine.
In addition to being accredited postgraduate lecture courses at the University of Basel (15581-01 Seminar: Immunology I and 17493-01 Seminar: Immunology II) the seminar series is also registered with the Veterinäramt Basel-Stadt for ongoing education. Attendees of relevant Immunomeetings have the opportunity to get credit towards “Aus- und Weiterbildungsveranstaltungen für Fachpersonal für Tierversuche”.
The Immunomeetings are coordinated by Prof. Gennaro De Libero, head of the Experimental Immunology Research Lab. For further information on the Immunomeetings please contact: Paula Cullen Baumann
Mike Recher, Immunodeficiency
Cat eye-related human immunodeficiency
uBICo Distinguished Speaker
Professor Ananda Goldrath, University of California, San Diego
Transcriptional programming of anti-tumor and anti-viral immunity
NB: This presentation will take place in the Kleiner Hörsaal, ZLF, Hebelstrasse 20, 4031 Basel
Emmanuel Contassot, Skin Biology
Involvement of innate immunity in severe cutaneous drug reactions
Elham Pishali, Cancer Immunology
Antisense oligonucleotide targeting PDL1 improves anti-tumour T Cell immunity
uBICo Distinguished Speakers and Guests:
Our next uBICo Distinguished Speaker will be Professor Ananda Goldrath from the University of California, San Diego who will visit on November 25th. Prof. Goldrath will make the following presentation:
"Transcriptional programming of anti-tumor and anti-viral immunity"
CD8⁺ T lymphocytes are a key element of endogenous cancer immunity and are frequently utilized in immunotherapies for treatments ranging from solid tumors to blood cancers. T cells exhibit extensive heterogeneity in functional parameters ranging from localization, metabolic profile, proliferative potential and capacity for self-renewal. By decoding the genetic instructions that direct the immune system to remember past encounters with pathogens and provide robust protection from reinfection, we aim to enhance immunity to infected and malignant cells.
A copy of the meeting flyer can be downloaded by clicking on the image below.
Details on other researchers who have visited Basel and taken part in the uBICo Distinguished Speaker series can be found below along with a list of guest speakers who have also presented at the Immunomeetings in recent years.
uBICo Distinguished speakers
Gillian Griffiths, Professor of Cell Biology and Immunology, Cambridge Institute for Medical Research, UK, April 29th 2019
Gioacchino Natoli, School of Medicine, Humanitas University, Milan, Italy, April 1st 2019
Marion Pepper University of Washington, Department of Immunology, Seattle, WA, USA, February 25, 2019
Oreste Acuto, Sir William Dunn School of Pathology, University of Oxford, November 19, 2018
Pedro Romero Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, September 24, 2018
Stuart Tangye, Garvan Institute of Research, Australia, March 12, 2018
James Di Santo, Insitut Pasteur, France, Feb 5th 2018
Matt Williams, University of Utah, School of Medicine, Salt Lake City, Utah, USA, Nov 13, 2017
Mitchel Kronenberg, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA, April 24, 2017
Vincenzo Cerundolo, Radcliffe Dept of Medicine, Oxford, UK, Feb 20 2017
Meinrad Busslinger, Research Institute of Molecular Pathology, Vienna, Austria Nov 28, 2016
Shane Crotty, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA, Sept 12, 2016
Cornelia Weyand, Stanford University, Dept. of Medicine, Division of Immunology and Rheumatology, CA, USA, Sept 5, 2016
Dirk Busch, Technische Universität München, Germany, April 11, 2016
Jean Laurent Casanova, University of New York, NY, USA, March 21, 2016
Axel Kallies, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, Feb 29, 2016
Rolf Zinkernagel, University of Zürich, Switzerland Jan 14, 2016
Ken Murphy, Washington University School of Medicine St-Louis, Dept. Of Pathology and Immunology, St- Louis, USA, Sept 7, 2015
Jeremy Luban, University of Massachusetts Medical School, Dept. Of Pathology and Immunology, MA, USA, May 7, 2015
Russell Jones, Goodman Cancer Centre, Dept. Of Physiology, McGill University, Montreal, Canada, April 20, 2015
Takeshi Egawa, Washington University School of Medicine, Division of Immunobiology, St- Louis, USA, March 20, 2015
Leo Kunz, Timm Schroeder lab, D-BSSE, May 25th, 2019
Marcus Thelen, Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana, May 6th, 2019
Hans-Christian Reinecker, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, February 4, 2019
Toru Miyazaki, Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, September 17, 2018
Olaf Rötzschke, Singapore Immunology Network (SIgN), Singapore, September 3, 2019
Fabio Grassi, Institute for Research and Biomedicine, Università della Svizzera italiana, Switzerland, April 9, 2018
Christoph Schneider, Dept of Medicine UCSF CA, USA, March 5, 2018
David Artis, Weill Cornell Medical College, New York, USA, March 16 2017
Maria Curotto de Lafaille, Singapore Immunology Network, Singapore, Sept 28, 2015